Concepts (201)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Proteomics | 7 | 2022 | 61 | 1.950 |
Why?
|
| Gene Expression Profiling | 6 | 2023 | 109 | 1.670 |
Why?
|
| Transcriptome | 8 | 2023 | 53 | 1.410 |
Why?
|
| Alzheimer Disease | 12 | 2023 | 1416 | 1.410 |
Why?
|
| Proteome | 5 | 2023 | 23 | 1.380 |
Why?
|
| RNA, Messenger | 3 | 2022 | 282 | 1.270 |
Why?
|
| Algorithms | 3 | 2023 | 310 | 1.150 |
Why?
|
| Cognitive Dysfunction | 8 | 2023 | 806 | 1.030 |
Why?
|
| Brain | 11 | 2023 | 1244 | 0.970 |
Why?
|
| Dementia | 3 | 2022 | 416 | 0.750 |
Why?
|
| Sjogren's Syndrome | 2 | 2020 | 3 | 0.680 |
Why?
|
| Multifactorial Inheritance | 1 | 2019 | 12 | 0.610 |
Why?
|
| Histones | 1 | 2019 | 28 | 0.610 |
Why?
|
| Blood Proteins | 1 | 2018 | 17 | 0.560 |
Why?
|
| ErbB Receptors | 2 | 2010 | 53 | 0.550 |
Why?
|
| Methotrexate | 1 | 2018 | 36 | 0.550 |
Why?
|
| Antirheumatic Agents | 1 | 2018 | 84 | 0.520 |
Why?
|
| Immunophenotyping | 1 | 2017 | 28 | 0.520 |
Why?
|
| Epigenomics | 1 | 2017 | 11 | 0.520 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2017 | 22 | 0.510 |
Why?
|
| Gene Regulatory Networks | 2 | 2015 | 17 | 0.510 |
Why?
|
| Genome-Wide Association Study | 4 | 2023 | 160 | 0.490 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2018 | 252 | 0.450 |
Why?
|
| Models, Genetic | 1 | 2015 | 32 | 0.440 |
Why?
|
| Humans | 28 | 2023 | 23495 | 0.390 |
Why?
|
| Aged | 13 | 2023 | 7709 | 0.380 |
Why?
|
| Phosphoproteins | 1 | 2010 | 24 | 0.330 |
Why?
|
| Aged, 80 and over | 10 | 2023 | 3874 | 0.310 |
Why?
|
| Amyloid beta-Peptides | 5 | 2023 | 210 | 0.290 |
Why?
|
| Cerebral Cortex | 2 | 2019 | 132 | 0.280 |
Why?
|
| Models, Biological | 2 | 2010 | 303 | 0.280 |
Why?
|
| Male | 15 | 2023 | 12823 | 0.270 |
Why?
|
| Cognition | 5 | 2023 | 1027 | 0.260 |
Why?
|
| Mass Spectrometry | 2 | 2022 | 24 | 0.260 |
Why?
|
| Female | 13 | 2023 | 13305 | 0.250 |
Why?
|
| Prefrontal Cortex | 3 | 2023 | 107 | 0.240 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2023 | 276 | 0.230 |
Why?
|
| Quantitative Trait Loci | 2 | 2021 | 26 | 0.210 |
Why?
|
| Cluster Analysis | 1 | 2023 | 39 | 0.200 |
Why?
|
| Benchmarking | 1 | 2023 | 29 | 0.200 |
Why?
|
| Neurotoxicity Syndromes | 1 | 2023 | 4 | 0.200 |
Why?
|
| Neurofibrillary Tangles | 2 | 2023 | 121 | 0.190 |
Why?
|
| Phosphorylation | 4 | 2017 | 130 | 0.190 |
Why?
|
| Protein Biosynthesis | 1 | 2022 | 14 | 0.180 |
Why?
|
| Nervous System Diseases | 1 | 2023 | 100 | 0.180 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2021 | 3 | 0.180 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2021 | 14 | 0.170 |
Why?
|
| Schizophrenia | 2 | 2011 | 45 | 0.170 |
Why?
|
| Movement Disorders | 1 | 2021 | 57 | 0.160 |
Why?
|
| tau Proteins | 4 | 2023 | 153 | 0.160 |
Why?
|
| Peptides | 1 | 2021 | 89 | 0.160 |
Why?
|
| Parkinsonian Disorders | 1 | 2023 | 170 | 0.160 |
Why?
|
| B-Lymphocyte Subsets | 1 | 2020 | 3 | 0.160 |
Why?
|
| Proteins | 1 | 2020 | 52 | 0.160 |
Why?
|
| Gene Expression Regulation | 2 | 2018 | 227 | 0.160 |
Why?
|
| Psychomotor Performance | 1 | 2021 | 165 | 0.160 |
Why?
|
| Adaptation, Psychological | 1 | 2020 | 168 | 0.150 |
Why?
|
| Acetylation | 1 | 2019 | 12 | 0.150 |
Why?
|
| Sleep Deprivation | 1 | 2019 | 35 | 0.150 |
Why?
|
| Neuropsychological Tests | 2 | 2019 | 917 | 0.150 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 5 | 1 | 2019 | 21 | 0.150 |
Why?
|
| MicroRNAs | 1 | 2019 | 38 | 0.150 |
Why?
|
| Pyrimidines | 2 | 2017 | 24 | 0.140 |
Why?
|
| Up-Regulation | 1 | 2019 | 145 | 0.140 |
Why?
|
| Genotype | 1 | 2019 | 265 | 0.140 |
Why?
|
| Biomarkers, Pharmacological | 1 | 2018 | 3 | 0.140 |
Why?
|
| Seasons | 1 | 2018 | 19 | 0.140 |
Why?
|
| Infliximab | 1 | 2018 | 17 | 0.140 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2018 | 8 | 0.140 |
Why?
|
| Cell Count | 1 | 2018 | 71 | 0.140 |
Why?
|
| Independent Living | 1 | 2020 | 240 | 0.140 |
Why?
|
| Monocytes | 1 | 2018 | 38 | 0.140 |
Why?
|
| Remission Induction | 1 | 2018 | 89 | 0.140 |
Why?
|
| Lymphocytes | 1 | 2018 | 51 | 0.140 |
Why?
|
| Cerebral Amyloid Angiopathy | 1 | 2019 | 96 | 0.140 |
Why?
|
| Phenotype | 3 | 2023 | 260 | 0.140 |
Why?
|
| Neutrophils | 1 | 2018 | 89 | 0.130 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2018 | 83 | 0.130 |
Why?
|
| Computational Biology | 1 | 2017 | 14 | 0.130 |
Why?
|
| Computer Simulation | 2 | 2010 | 173 | 0.130 |
Why?
|
| Motor Activity | 1 | 2019 | 274 | 0.130 |
Why?
|
| Alternative Splicing | 1 | 2017 | 16 | 0.130 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2017 | 13 | 0.130 |
Why?
|
| RNA-Binding Proteins | 1 | 2017 | 19 | 0.130 |
Why?
|
| ADAM Proteins | 1 | 2017 | 41 | 0.130 |
Why?
|
| Case-Control Studies | 1 | 2018 | 507 | 0.130 |
Why?
|
| Chicago | 1 | 2019 | 848 | 0.120 |
Why?
|
| Parkinson Disease | 1 | 2023 | 595 | 0.120 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2017 | 57 | 0.120 |
Why?
|
| Imidazoles | 1 | 2017 | 62 | 0.120 |
Why?
|
| Longitudinal Studies | 1 | 2019 | 1106 | 0.120 |
Why?
|
| Signal Transduction | 2 | 2010 | 392 | 0.120 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2017 | 111 | 0.120 |
Why?
|
| Gene Expression | 3 | 2023 | 180 | 0.120 |
Why?
|
| Severity of Illness Index | 1 | 2018 | 807 | 0.110 |
Why?
|
| Markov Chains | 1 | 2015 | 30 | 0.110 |
Why?
|
| Bayes Theorem | 1 | 2015 | 32 | 0.110 |
Why?
|
| Monte Carlo Method | 1 | 2015 | 48 | 0.110 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2011 | 55 | 0.110 |
Why?
|
| Cognition Disorders | 1 | 2019 | 726 | 0.100 |
Why?
|
| Aging | 2 | 2019 | 1180 | 0.100 |
Why?
|
| Risk Factors | 1 | 2019 | 2026 | 0.100 |
Why?
|
| Epidermal Growth Factor | 2 | 2010 | 26 | 0.100 |
Why?
|
| Adult | 3 | 2023 | 7090 | 0.090 |
Why?
|
| Sequence Analysis, RNA | 2 | 2023 | 25 | 0.090 |
Why?
|
| Middle Aged | 4 | 2018 | 8096 | 0.090 |
Why?
|
| Chromatography, Liquid | 1 | 2010 | 15 | 0.080 |
Why?
|
| Tyrosine | 1 | 2010 | 22 | 0.080 |
Why?
|
| Amino Acid Substitution | 1 | 2010 | 20 | 0.080 |
Why?
|
| DNA Copy Number Variations | 1 | 2010 | 5 | 0.080 |
Why?
|
| Linear Models | 2 | 2023 | 203 | 0.080 |
Why?
|
| Twins, Monozygotic | 1 | 2010 | 8 | 0.080 |
Why?
|
| Polymorphism, Single Nucleotide | 3 | 2021 | 176 | 0.080 |
Why?
|
| Diseases in Twins | 1 | 2010 | 9 | 0.080 |
Why?
|
| Blotting, Western | 1 | 2010 | 132 | 0.080 |
Why?
|
| Treatment Outcome | 1 | 2018 | 3058 | 0.080 |
Why?
|
| Cohort Studies | 3 | 2019 | 1500 | 0.080 |
Why?
|
| Cell Line | 1 | 2010 | 244 | 0.080 |
Why?
|
| Mutation | 1 | 2010 | 329 | 0.070 |
Why?
|
| Animals | 2 | 2019 | 3321 | 0.070 |
Why?
|
| Phosphotyrosine | 1 | 2008 | 1 | 0.070 |
Why?
|
| Autopsy | 2 | 2019 | 260 | 0.070 |
Why?
|
| Neurons | 2 | 2021 | 273 | 0.070 |
Why?
|
| Nerve Tissue Proteins | 2 | 2020 | 118 | 0.060 |
Why?
|
| Computer Graphics | 1 | 2006 | 4 | 0.060 |
Why?
|
| Software | 1 | 2006 | 51 | 0.060 |
Why?
|
| Kinetics | 1 | 2006 | 176 | 0.060 |
Why?
|
| Molecular Biology | 1 | 2023 | 9 | 0.050 |
Why?
|
| Base Sequence | 1 | 2023 | 103 | 0.050 |
Why?
|
| DNA | 1 | 2023 | 99 | 0.050 |
Why?
|
| Organ Size | 1 | 2023 | 87 | 0.050 |
Why?
|
| Protein Aggregates | 1 | 2023 | 5 | 0.050 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2023 | 11 | 0.050 |
Why?
|
| Mitochondria | 1 | 2023 | 55 | 0.050 |
Why?
|
| Adaptor Protein Complex 1 | 1 | 2023 | 4 | 0.050 |
Why?
|
| Adaptor Protein Complex beta Subunits | 1 | 2023 | 4 | 0.050 |
Why?
|
| RNA | 1 | 2023 | 29 | 0.050 |
Why?
|
| Nerve Growth Factors | 1 | 2023 | 33 | 0.050 |
Why?
|
| Neuropathology | 1 | 2023 | 63 | 0.050 |
Why?
|
| Receptors, Estrogen | 1 | 2023 | 62 | 0.050 |
Why?
|
| Alleles | 1 | 2021 | 172 | 0.040 |
Why?
|
| Ubiquitin-Activating Enzymes | 1 | 2020 | 4 | 0.040 |
Why?
|
| Actinin | 1 | 2020 | 7 | 0.040 |
Why?
|
| Vesicular Transport Proteins | 1 | 2020 | 8 | 0.040 |
Why?
|
| Molecular Chaperones | 1 | 2020 | 8 | 0.040 |
Why?
|
| GPI-Linked Proteins | 1 | 2020 | 16 | 0.040 |
Why?
|
| Epoxide Hydrolases | 1 | 2020 | 8 | 0.040 |
Why?
|
| Neuropeptides | 1 | 2020 | 22 | 0.040 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2020 | 43 | 0.040 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2020 | 46 | 0.040 |
Why?
|
| Germinal Center | 1 | 2020 | 1 | 0.040 |
Why?
|
| SOXC Transcription Factors | 1 | 2020 | 1 | 0.040 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 2020 | 35 | 0.040 |
Why?
|
| B-Lymphocytes | 1 | 2020 | 49 | 0.040 |
Why?
|
| Thy-1 Antigens | 1 | 2019 | 1 | 0.040 |
Why?
|
| Sensory Gating | 1 | 2019 | 3 | 0.040 |
Why?
|
| Exploratory Behavior | 1 | 2019 | 9 | 0.040 |
Why?
|
| Schizophrenic Psychology | 1 | 2019 | 13 | 0.040 |
Why?
|
| Nerve Net | 1 | 2019 | 34 | 0.040 |
Why?
|
| Sclerosis | 1 | 2019 | 54 | 0.040 |
Why?
|
| Promoter Regions, Genetic | 1 | 2019 | 86 | 0.040 |
Why?
|
| Microglia | 1 | 2019 | 108 | 0.040 |
Why?
|
| Plaque, Amyloid | 1 | 2019 | 90 | 0.040 |
Why?
|
| Mice, Transgenic | 1 | 2019 | 179 | 0.040 |
Why?
|
| Neuroimaging | 1 | 2019 | 105 | 0.040 |
Why?
|
| Memory, Episodic | 1 | 2019 | 81 | 0.040 |
Why?
|
| Cognitive Aging | 1 | 2019 | 64 | 0.040 |
Why?
|
| Memory | 1 | 2019 | 225 | 0.040 |
Why?
|
| Sleep Wake Disorders | 1 | 2019 | 112 | 0.040 |
Why?
|
| Immunohistochemistry | 1 | 2019 | 340 | 0.040 |
Why?
|
| Neural Stem Cells | 1 | 2018 | 9 | 0.030 |
Why?
|
| Lewy Bodies | 1 | 2019 | 151 | 0.030 |
Why?
|
| DNA Methylation | 1 | 2019 | 130 | 0.030 |
Why?
|
| Genetic Association Studies | 1 | 2018 | 58 | 0.030 |
Why?
|
| TDP-43 Proteinopathies | 1 | 2019 | 87 | 0.030 |
Why?
|
| Apolipoprotein E4 | 1 | 2019 | 186 | 0.030 |
Why?
|
| Hippocampus | 1 | 2019 | 200 | 0.030 |
Why?
|
| Logistic Models | 1 | 2018 | 357 | 0.030 |
Why?
|
| Sleep | 1 | 2019 | 272 | 0.030 |
Why?
|
| HCT116 Cells | 1 | 2017 | 11 | 0.030 |
Why?
|
| Structure-Activity Relationship | 1 | 2017 | 36 | 0.030 |
Why?
|
| Exons | 1 | 2017 | 29 | 0.030 |
Why?
|
| Genome, Human | 1 | 2017 | 34 | 0.030 |
Why?
|
| RNA, Small Interfering | 1 | 2017 | 76 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2021 | 1528 | 0.030 |
Why?
|
| Astrocytes | 1 | 2018 | 126 | 0.030 |
Why?
|
| Transcription, Genetic | 1 | 2017 | 95 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 2019 | 533 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2018 | 313 | 0.030 |
Why?
|
| Biomarkers | 1 | 2018 | 486 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2018 | 783 | 0.030 |
Why?
|
| Mice | 1 | 2019 | 1264 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2019 | 907 | 0.030 |
Why?
|
| Coenzyme A Ligases | 1 | 2011 | 5 | 0.020 |
Why?
|
| Homozygote | 1 | 2011 | 15 | 0.020 |
Why?
|
| Gene Dosage | 1 | 2010 | 17 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2010 | 114 | 0.020 |
Why?
|
| Epigenesis, Genetic | 1 | 2010 | 61 | 0.020 |
Why?
|
| src-Family Kinases | 1 | 2008 | 6 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2008 | 246 | 0.020 |
Why?
|
| Time Factors | 1 | 2008 | 1276 | 0.010 |
Why?
|